Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts

MLA

Younshin Jung, et al. “Anti-Fibrogenic Effect of PPAR-γ Agonists in Human Intestinal Myofibroblasts.” BMC Gastroenterology, vol. 17, June 2017. EBSCOhost, https://doi.org/10.1186/s12876-017-0627-4.

APA

Younshin Jung, Jun Bon Koo, Kwang Jae Lee, Jun Hwan Yoo, Duk-Hwan Kim, Jong Woo Kim, Jongman Yoo, Ki Baik Hahm, Kee Myung Lee, Sung Jae Shin, Gwangil Kim, Sung Pyo Hong, & Myeong-Ok Nam. (2017). Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. BMC Gastroenterology, 17. https://doi.org/10.1186/s12876-017-0627-4

Chicago

Younshin Jung, Jun Bon Koo, Kwang Jae Lee, Jun Hwan Yoo, Duk-Hwan Kim, Jong Woo Kim, Jongman Yoo, et al. 2017. “Anti-Fibrogenic Effect of PPAR-γ Agonists in Human Intestinal Myofibroblasts.” BMC Gastroenterology 17 (June). doi:10.1186/s12876-017-0627-4.